We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.57B
AUM Growth
+$643M
Cap. Flow
+$235M
Cap. Flow %
3.1%
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$71M
2
BAX icon
Baxter International
BAX
+$60.7M
3
TMUS icon
T-Mobile US
TMUS
+$60.1M
4
PRGO icon
Perrigo
PRGO
+$53.7M
5
NRG icon
NRG Energy
NRG
+$50.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.11%
2 Industrials 11.84%
3 Consumer Discretionary 11.65%
4 Technology 10.61%
5 Financials 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFX icon
226
Teleflex
TFX
$6.06B
$8.12M 0.11%
70,707
+31,257
+79% +$3.54M
HDS
227
DELISTED
HD Supply Holdings, Inc.
HDS
$8.01M 0.11%
271,584
-202,599
-43% -$5.68M
BA icon
228
Boeing
BA
$190B
$7.99M 0.11%
61,478
+6,272
+11% +$795K
CDNS icon
229
Cadence Design Systems
CDNS
$92.8B
$7.88M 0.1%
+415,297
New +$7.45M
VRSK icon
230
Verisk Analytics
VRSK
$24.6B
$7.85M 0.1%
122,505
+85,496
+231% +$5.32M
CPRT icon
231
Copart
CPRT
$26.8B
$7.64M 0.1%
1,674,672
+1,580,928
+1,686% +$6.78M
FOE
232
DELISTED
Ferro Corporation
FOE
$7.61M 0.1%
587,219
+20,531
+4% +$270K
EMC
233
DELISTED
EMC CORPORATION
EMC
$7.56M 0.1%
254,143
+171,306
+207% +$4.99M
PCTY icon
234
Paylocity
PCTY
$7.91B
$7.5M 0.1%
287,063
+277,084
+2,777% +$6.96M
INFA
235
DELISTED
INFORMATICA CORP
INFA
$7.46M 0.1%
195,535
+32,205
+20% +$1.16M
HII icon
236
Huntington Ingalls Industries
HII
$12.5B
$7.38M 0.1%
+65,573
New +$6.89M
ORCL icon
237
Oracle
ORCL
$416B
$7.34M 0.1%
163,256
+153,610
+1,592% +$6.25M
BRSL
238
Brightstar Lottery PLC
BRSL
$2.08B
$7.33M 0.1%
425,105
+242,283
+133% +$4.07M
INTC icon
239
Intel
INTC
$510B
$7.28M 0.1%
200,514
-169,802
-46% -$5.91M
LOGM
240
DELISTED
LogMein, Inc.
LOGM
$7.23M 0.1%
146,458
-51,225
-26% -$2.46M
CFR icon
241
Cullen/Frost Bankers
CFR
$10.3B
$7.19M 0.09%
+101,761
New +$7.67M
ACHC icon
242
Acadia Healthcare
ACHC
$3B
$7.08M 0.09%
115,733
+73,306
+173% +$4.27M
LNKD
243
DELISTED
LinkedIn Corporation
LNKD
$7.05M 0.09%
30,703
-41,269
-57% -$8.94M
CCK icon
244
Crown Holdings
CCK
$13.3B
$7.04M 0.09%
138,228
+135,661
+5,285% +$6.54M
WPX
245
DELISTED
WPX Energy, Inc.
WPX
$7.03M 0.09%
+604,388
New +$9.65M
XOMA
246
DELISTED
Xoma
XOMA
$6.88M 0.09%
95,765
+79,940
+505% +$6.85M
HD icon
247
Home Depot
HD
$352B
$6.83M 0.09%
+65,066
New +$6.32M
VMW
248
DELISTED
VMware, Inc
VMW
$6.8M 0.09%
82,461
-21,759
-21% -$1.86M
DBRG icon
249
DigitalBridge
DBRG
$2.94B
$6.75M 0.09%
74,718
+45,153
+153% +$3.58M
AMP icon
250
Ameriprise Financial
AMP
$49.6B
$6.72M 0.09%
50,792
-114,398
-69% -$14.5M

Similar funds

Marshall Wace's Q4 2014 Portfolio in Review

As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.

  • Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
  • Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
  • Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
  • Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
  • Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
  • Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
  • Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.

Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.